As expected, the ratio of NADPH/NADP+ was increased in PCK1-overexpressing hepatoma cells (Figure 3A), while decreased in PCK1-KO PLC/PRF/5 cells (Figure 3B), compared to control cells. This evidence concerns the gene HSPG2 and hepatocellular carcinoma.